Zevtera / Mabelio (ceftobiprole)

Indicaton

Hospital- and community-acquired pneumonia

Therapeutic indications

Infectious disease

Type of product

Small molecule

Table

Phase

Marketed
Partnering status

Partnered
Partner

Advanz for Europe (excl. Nordics) and Israel; Unimedic for Nordics; Hikma for MENA region, Knight Grupo Biotoscana for Latin America; Avir for Canada, CR Gosun for China, JSC Lancet for Eurasian Economic Union
Available in

Major European and several international markets

You may also be interested in

Regkirona (regdanvimab)

Regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (COVID-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19

Marketed

Cadazolid

Crohn's disease

Phase II started

Zevtera / Mabelio (ceftobiprole)

Staphylococcus aureus bacteremia

Phase III completed